# Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

> **NCT00827489** · PHASE1 · TERMINATED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 72 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** HTC-867
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00827489
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2009-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827489, "Study Evaluating HTC-867 in Healthy Young and Elderly Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00827489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*